Best Therapy for Refractory Erectile Dysfunction
For patients with refractory erectile dysfunction, penile prosthesis implantation is the most effective treatment option when oral medications, intracavernosal injections, and vacuum devices have failed. 1
Definition and Assessment
- Refractory erectile dysfunction refers to persistent ED that fails to respond adequately to first-line therapies, particularly PDE5 inhibitors 2
- Common causes include diabetes mellitus, cardiovascular disease, post-radical prostatectomy, and severe vascular disease 2
- Before proceeding to more invasive therapies, ensure that PDE5 inhibitor trials were adequate (proper dosing, timing, sexual stimulation) 1
Treatment Algorithm for Refractory ED
Step 1: Optimize PDE5 Inhibitor Therapy
- Try a different PDE5 inhibitor if one has failed (sildenafil, tadalafil, or vardenafil) 1
- Consider higher dosages within safe limits 3
- Vardenafil may be effective in some patients who failed sildenafil therapy 4
- Tadalafil has shown efficacy in difficult-to-treat populations including post-prostatectomy patients and diabetics 3
Step 2: Second-Line Therapies
Intracavernosal injection therapy:
Intraurethral alprostadil suppositories:
Vacuum erection devices (VED):
Step 3: Combination Therapies
- Combining PDE5 inhibitors with intraurethral or intracavernosal alprostadil may improve efficacy 6
- Combination of behavioral and pharmacological approaches may yield better results than either alone 1
- Low-intensity extracorporeal shockwave therapy may be used in combination with PDE5 inhibitors for mild to moderate ED 6
Step 4: Definitive Treatment - Penile Prosthesis
- Gold standard for refractory ED when other treatments have failed 1
- High satisfaction rates for both patients and partners 5
- Modern devices have low mechanical failure and infection rates 5
- Requires thorough counseling regarding post-operative expectations 1
- Surgery should not be performed in the presence of systemic, cutaneous, or urinary tract infection 1
Special Considerations
Cardiovascular risk:
- Assess cardiovascular risk before initiating ED therapy 1
- High-risk patients (unstable angina, uncontrolled hypertension, recent MI) should have cardiac condition stabilized before ED treatment 1
- Safe time interval between nitrate use and PDE5 inhibitors: 24 hours for sildenafil, 48 hours for tadalafil 1
Post-prostatectomy ED:
Diabetic ED:
Experimental Approaches
- Low-intensity shock wave therapy shows promise for mild to moderate ED 6
- Regenerative therapies (stem cell therapy, gene therapy) are still investigational 7
- Surgical approaches like penile revascularization may benefit selected patients with isolated arterial insufficiency following pelvic trauma 6
- Surgical management including injection of bulking agents should be considered experimental and only used in approved clinical trials 1
Common Pitfalls to Avoid
- Failing to address psychological factors that may contribute to treatment resistance 1
- Not optimizing PDE5 inhibitor therapy before moving to more invasive options 1
- Overlooking medication interactions, particularly with nitrates 1
- Neglecting to periodically reassess efficacy, side effects, and changes in health status for patients on continuing therapy 1
- Performing penile prosthesis surgery in the presence of infection 1